PhD Student(Alumni)
University Freiburg Medical Centre
Department of Medicine, Div. of Haematology and Oncology
- +49 (0) 761 / 270 -71980 or -37280
- gabriele.greve@uniklinik-freiburg.de
- Homepage
2017 | PhD thesis, Albert-Ludwigs-University of Freiburg |
2010 - 2017 | PhD student in the lab of Prof. Dr. Michel Lübbert, Division of Haematology and Oncology, University Freiburg Medical Centre |
2010 | Diploma thesis in Molecular Biology and Genetics, Albert-Ludwigs-University of Freiburg |
2001 - 2010 | Study of Biology, Albert-Ludwigs-University of Freiburg |
Publications
- Blum S., Greve G. and Lubbert M. (2017) Innovative strategies for adverse karyotype acute myeloid leukemia. Curr Opin Hematol 24, 89-98.
- Schiffmann I., Greve G., Jung M. and Lubbert M. (2016) Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives. Epigenetics 11, 858-870.
- Greve G., Schiffmann I., Pfeifer D., Pantic M., Schuler J. and Lubbert M. (2015) The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells. BMC Cancer 15, 947.
- Greve G., Schiffmann I. and Lubbert M. (2015) Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid. J Cancer Res Clin Oncol 141, 2171-2180.